Proton and photon radiotherapy in stage III NSCLC: effects on hematological toxicity and adjuvant immune therapy

CONCLUSION: IMPT was associated with a lower incidence of severe lymphopenia and anemia, better PS after CCRT and a higher probability of receiving adjuvant durvalumab.PMID:38000689 | DOI:10.1016/j.radonc.2023.110019

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 24, 2023 Category: Radiology Authors: Francesco Cortiula Lizza E L Hendriks Robin Wijsman Ruud Houben Michelle Steens Sarah Debakker Richard Canters Marco Trovo Nanna M Sijtsema Anne G H Niezink Mirko Unipan Susanna Urban Anna Michelotti Safiye Dursun Gerben Bootsma Djoya Hattu Joost J Nuytte Source Type: research